Copyright
©2013 Baishideng Publishing Group Co.
World J Crit Care Med. Nov 4, 2013; 2(4): 48-55
Published online Nov 4, 2013. doi: 10.5492/wjccm.v2.i4.48
Published online Nov 4, 2013. doi: 10.5492/wjccm.v2.i4.48
Table 1 Comparison of cytokines between MKN-45 and MKN-45P
| IL-1β(pg/mL) | IL-6 (pg/mL) | IL-8 (pg/mL) | VEGF (pg/mL) | MMP-2 (ng/mL) | TIMP-1 (ng/mL) | |
| MKN-45 | 0.9 ± 0.7 | 1.2 ± 0.7 | 381.9 ± 147.1 | 1335.0 ± 624.3 | 0.3 ± 0.1 | 2.7 ± 1.8 |
| MKN-45P | 0.4 ± 0.2 | 2.9 ± 0.6 | 891.4 ± 210.2 | 3806.0 ± 229.8 | 0.7 ± 0.5 | 6.0 ± 4.0 |
| P value | 0.109 | 0.045 | 0.011 | 0.013 | 0.021 | 0.126 |
- Citation: Aoyagi K, Kouhuji K, Miyagi M, Kizaki J, Isobe T, Hashimoto K, Shirouzu K. Molecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer. World J Crit Care Med 2013; 2(4): 48-55
- URL: https://www.wjgnet.com/2220-3141/full/v2/i4/48.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v2.i4.48